Ledger.Open graph →
SEC Form D · filed July 16, 2018

Jecure Therapeutics, Inc

Offering
$3.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Matthew C. Mcclelland · Trenton, MIDirectorPeter Kambolin · New York, NYExec · DirectorJeffrey Zielinski · Singapore, U0DirectorSame Systematic Alpha Cryptocurrency GP, LLC · New York, NYDirectorJay Luo Jiabin · Singapore, U0ExecDaniel J. Goldstein · Rochester, NYExecE. P. Saunders · Rochester, NYDirectorCharles R. Knittle · Rochester, NYExec · DirectorBruce E. Bender · Rochester, NYDirectorAleksandrs Zavoronkovs · London, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗